• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

IV alteplase improves functional outcomes in patients with stroke of unknown onset

byVineeth BhogadiandTeddy Guo
December 8, 2020
in Emergency, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In patients who had a stroke with unknown time of onset and DWI-FLAIR or perfusion mismatch, IV alteplase resulted in better functional outcomes at 90 days compared to placebo or current standard care.

2. The prevalence of severe disability or death was lower with IV alteplase, but was also associated with increased risk of symptomatic intracranial hemorrhage and higher mortality.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Thrombolysis with intravenous alteplase is the current standard of care for acute ischemic stroke. Treatment with alteplase has traditionally been reserved for patients with known time of symptom onset, but in approximately 20-25% of patients with stroke, time of symptom onset is unknown. However, several individual trials utilizing imaging biomarkers to select patients with unknown time of stroke onset for IV thrombolysis have shown promise with net clinical benefit. This systematic review and meta-analysis included individual patient data from four randomized-controlled trials comparing IV alteplase with placebo or standard of care in adults with stroke of unknown time of onset. Patients were selected using imaging biomarkers (MRI diffusion weighted imaging-fluid attenuated inversion recovery [DWI-FLAIR] mismatch or perfusion CT/MRI based penumbral imaging) to help identify salvageable tissue. Treatment with alteplase was associated with significantly improved functional outcomes including functional independence at 90 days compared to control. Additionally, a net benefit across all functional outcomes was observed with thrombolysis despite an increased risk of symptomatic intracranial hemorrhage and higher mortality. Prevalence of severe disability or death was lower with IV alteplase. This study was limited by the overall small number of patients included in the meta-analysis allowing for limited conclusions to be drawn from sub-group analysis. Additionally, the conclusions of this meta-analysis may be driven by the results of the WAKE-UP trial which represented most patients included in the analysis.

Click to read the study in The Lancet

Relevant Reading: MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset

RELATED REPORTS

2 Minute Medicine Rewind June 30, 2025

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

In-Depth [systematic review]: This systematic review and meta-analysis included individual patient data from four randomized-controlled trials comparing IV alteplase with placebo or standard of care in adults with stroke of unknown time of onset and imaging mismatch (perfusion-diffusion MRI, perfusion CT or MRI with DWI-FLAIR). The primary outcome was defined as a favourable score of 0-1 on the modified Rankin Scale (mRS) to identify patients with no symptoms or minimal symptoms with no functional disability at 90 days after stroke.

A total of four trials met the inclusion criteria with individual patient data for 843 patients (mean age = 68.5 years; 38% female) included in the analysis. Overall, a favorable outcome (mRS score 0-1) at 90 days was observed in 199 of 420 (47%) patients in the alteplase group and in 160 of 409 (39%) patients in the control group (adjusted odds ratio [OR] 1.49, 95% CI 1.10 to 2.03; p=0.011) with low heterogeneity across studies (I2=27%). Alteplase treatment was associated with improved functional outcomes with lower mRS scores (adjusted common OR 1.38, 95% CI 1.05 to 1.80; p=0.019) and increased proportion of patients who reached functional independence (mRS score 0-2) at 90 days (adjusted OR 1.50, 95% CI 1.06 to 2.12; p=0.022) compared to control. In the alteplase group, 21% of patients were severely disabled or died (mRS score 4-6) compared to 25% of patients in the control group (adjusted OR 0.76, 95% CI 0.52 to 1.11; p=0.14). However, overall, 6% of patients died in the alteplase group compared to 3% among controls (adjusted OR 2.06, 95% CI 1.03 to 4.09; p=0.040) Patients receiving alteplase had a higher overall prevalence of symptomatic intracranial hemorrhage compared to controls (3% vs <1%, adjusted OR 5.58, 95% CI 1.22 to 25.50; p=0.024). Overall, study findings suggest that IV alteplase in patients with a stroke of unknown time of onset (with a DWI-FLAIR or perfusion mismatch) is associated with improved functional outcomes and functional independence.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: alteplaseischemic strokestrokethrombolysis
Previous Post

Consumption of red meat associated with elevated risk of coronary heart disease

Next Post

#VisualAbstract: Rilonacept may lower pericarditis recurrence in patients with relapsing pericarditis

RelatedReports

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Weekly Rewinds

2 Minute Medicine Rewind June 30, 2025

June 30, 2025
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Neurology

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

June 20, 2025
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Chronic Disease

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

June 4, 2025
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Chronic Disease

Personalized visual perceptual learning digital therapy may improve vision post-stroke

May 30, 2025
Next Post
Sotagliflozin reduces hospitalizations and urgent visits for patients with diabetes and worsening heart failure

#VisualAbstract: Rilonacept may lower pericarditis recurrence in patients with relapsing pericarditis

Behavioral dysregulation in infancy predicts later child mental health

Hyoscine butylbromide and acetaminophen have comparable effects for pediatric non-specific colicky abdominal pain

1 in 5 US women report delayed contraceptive initiation after sexual debut

Improved contraception use with progestogen-only pill and rapid access vs emergency contraception

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Lactated Ringer’s Solution Does Not Improve Outcomes Relative to Normal Saline
  • 2MM: AI Roundup – FDA’s AI Push, Trial Speedups with Real-World Data, Smart Surgical Monitors, and Regulatory Overhaul Begins [July 2nd, 2025]
  • The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.